TipRanks
Go Ultimate55% OFF

Zepp Health (ZEPPN) Stock Price & Analysis

ZEPPN Stock Chart & Stats

MX$254.00MX$0.00(0.00%)
At close:
MXN 250MXN 300MXN 350MXN 40020 Feb24 Mar
Day’s Range
MXN 254.00 - MXN 254.00
52-Week Range
MXN 70.00 - MXN 411.00
Previous Close
MXN 254.00
Volume
0
Average Volume (3M)
0
Market Cap
MXN 606.73M
Enterprise Value
MXN 222.21M
Total Cash (Recent Filing)
MXN 721.36M
Total Debt (Recent Filing)
MXN 1.67B
Price to Earnings (P/E)
―
Beta
-0.66
Next Earnings
Nov 23, 2026 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Revenue Growth And Market Share

Strong first-quarter growth combined with improved value share in major regions indicates broader consumer adoption and stronger competitive positioning. If maintained, this expanding market presence can support recurring product demand, channel leverage, and a more durable foundation for future revenue growth.

Premium Product Mix

Rising average selling prices and greater premium-model penetration show that Zepp is moving beyond volume-led competition toward higher-value products. A richer mix can improve revenue quality, strengthen brand perception, and provide greater opportunity to absorb development and marketing costs over time.

Integrated Wearable Ecosystem

A growing software ecosystem can make Amazfit devices more useful and increase user loyalty beyond the initial hardware purchase. Integrating training intelligence, health data, and device experiences across products supports differentiation and may create a durable platform advantage as the portfolio expands.

Bears Say

Persistent Unprofitability

Continued net losses show that revenue growth and higher-value products have not yet translated into sustainable earnings. Ongoing unprofitability limits internally funded investment, leaves results sensitive to spending and currency movements, and makes the turnaround dependent on further margin and operating-cost improvement.

Negative Cash Generation And Leverage

Negative operating and free cash flow indicate that the business has not consistently funded operations internally, while debt slightly exceeds equity. This combination reduces financial flexibility and could constrain product investment or increase reliance on balance-sheet support if losses continue through the next several quarters.

Cost And Margin Pressure

Input-cost inflation and currency pressure can erode gross margin even as product mix improves. At the same time, elevated investment in research, marketing, and brand building raises the break-even threshold, making profitable growth dependent on successful launches, pricing discipline, and operating-expense control.

Zepp Health News

ZEPPN FAQ

What was Zepp Health’s price range in the past 12 months?
Zepp Health lowest stock price was Mex$70.00 and its highest was Mex$411.00 in the past 12 months.
What is Zepp Health’s market cap?
Zepp Health’s market cap is Mex$606.73M.
When is Zepp Health’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Zepp Health’s earnings last quarter?
Zepp Health released its earnings results on Sep 02, 2026. The company reported -Mex$0.939 earnings per share for the quarter.
Is Zepp Health overvalued?
According to Wall Street analysts Zepp Health’s price is currently Undervalued.
Does Zepp Health pay dividends?
Zepp Health does not currently pay dividends.
What is Zepp Health’s EPS estimate?
Zepp Health’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Zepp Health have?
Zepp Health has 8,460,126 shares outstanding.
What happened to Zepp Health’s price movement after its last earnings report?
Zepp Health reported an EPS of -Mex$0.939 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Zepp Health?
Currently, no hedge funds are holding shares in MX:ZEPPN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology